Patents by Inventor Maria del Carmen Cuevas Marchante

Maria del Carmen Cuevas Marchante has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG ANTIBODY CONJUGATES
    Publication number: 20240131180
    Abstract: Drug conjugates having formula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, (I) wherein D is covalently attached via a hydroxy or amine group to (X)b if any, or (AA)w if any, or to (T)g if any, or (L); that are useful in the treatment of cancer.
    Type: Application
    Filed: April 21, 2021
    Publication date: April 25, 2024
    Inventors: Alfonso LATORRE LOZANO, Valentín MARTÍNEZ BARRASA, Andrés M. FRANCESCH SOLLOSO, María Del Carmen CUEVAS MARCHANTE
  • Antitumoral compounds
    Patent number: 11713325
    Abstract: A compound of general formula I and pharmaceutical compositions, kits, methods of making, and methods for treating cancer using the same.
    Type: Grant
    Filed: April 5, 2022
    Date of Patent: August 1, 2023
    Assignee: Pharma Mar, S.A.
    Inventors: Maria del Carmen Cuevas Marchante, Andres Francesch Solloso, Valentin Martinez Barrasa
  • DRUG ANTIBODY CONJUGATES
    Publication number: 20230218774
    Abstract: Drug conjugates having formula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt or ester thereof, wherein D is covalently attached via a hydroxy group at OR1, OR3 or ZH, or a thiol group at ZH to (X)b if any, or (AA)w if any, or to (T)g if any, or (L); that are useful in the treatment of cancer.
    Type: Application
    Filed: September 4, 2020
    Publication date: July 13, 2023
    Inventors: Alfonso Latorre Lozano, Agustín Gutiérrez Loriente, Maria Del Carmen Cuevas Marchante
  • Antitumoral Compounds
    Publication number: 20220242883
    Abstract: A compound of general formula I and pharmaceutical compositions, kits, methods of making, and methods for treating cancer using the same.
    Type: Application
    Filed: April 5, 2022
    Publication date: August 4, 2022
    Inventors: María del Carmen Cuevas Marchante, Andres Francesch Solloso, Valentin Martinez Barrasa
  • Antitumoral compounds
    Patent number: 11339180
    Abstract: A compound of general formula I and pharmaceutical compositions, kits, methods of making, and methods for treating cancer using the same.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: May 24, 2022
    Assignee: PHARMA MAR, S.A.
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral compounds
    Patent number: 11332480
    Abstract: A compound of general formula I, wherein X, R1-R4 take various meanings, for use in the treatment of cancer.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: May 17, 2022
    Assignee: PHARMA MAR, S.A.
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • ANTICANCER COMPOUNDS
    Publication number: 20220056021
    Abstract: Anticancer compounds of formula (I) and derivatives thereof are provided.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Inventors: María Jesús Martín López, Raquel Rodríguez Acebes, Patricia Gema Cruz López, Andrés M. Francesch Solloso, Maria del Carmen Cuevas Marchante
  • ANTITUMORAL COMPOUNDS
    Publication number: 20210246146
    Abstract: A compound of general formula I and pharmaceutical compositions, kits, methods of making, and methods for treating cancer using the same.
    Type: Application
    Filed: April 2, 2021
    Publication date: August 12, 2021
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral Compounds
    Publication number: 20210070775
    Abstract: A compound of general formula I, wherein X, R1-R4 take various meanings, for use in the treatment of cancer.
    Type: Application
    Filed: April 27, 2018
    Publication date: March 11, 2021
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral compounds
    Patent number: 10538535
    Abstract: A compound of general formula I, wherein X, R1-R4 take various meanings, for use in the treatment of cancer.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: January 21, 2020
    Assignee: PHARMA MAR, S.A.
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral compounds
    Patent number: 10442820
    Abstract: A compound of general formula I, wherein X, R1-R4 take various meanings, for use in the treatment of cancer.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: October 15, 2019
    Assignee: PHARMA MAR, S.A.
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral Compounds
    Publication number: 20180312529
    Abstract: A compound of general formula I, wherein X, R1-R4 take various meanings, for use in the treatment of cancer.
    Type: Application
    Filed: April 27, 2018
    Publication date: November 1, 2018
    Inventors: María del Carmen Cuevas Marchante, Andrés Francesch Solloso, Valentín Martínez Barrasa
  • Antitumoral compounds
    Patent number: 9827257
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: November 28, 2017
    Assignee: PHARMA MAR, S.A.
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-Ibarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • Antitumoral compounds
    Patent number: 9750759
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: September 5, 2017
    Assignee: Pharma Mar, S.A.
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-Ibarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • Synthetic process for the manufacture of ecteinascidin compounds
    Patent number: 9428524
    Abstract: This invention relates to compounds of formula II: wherein R1, R2, ProtSH, and ProtNH are as defined, to processes for the synthesis of ecteinascidins of formula I from compounds of formula II, and to processes for the synthesis of compounds of formula II.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: August 30, 2016
    Assignee: PHARMA MAR, S.A.
    Inventors: Ma Jesús Martin López, Andrés Francesch Solloso, Maria del Carmen Cuevas Marchante
  • ANTITUMORAL COMPOUNDS
    Publication number: 20150342972
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Application
    Filed: August 12, 2015
    Publication date: December 3, 2015
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-lbarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • ANTITUMORAL COMPOUNDS
    Publication number: 20150344454
    Abstract: A compound of general formula (I) wherein A, Y, R1, R2, R3, R4, R5, and R6 take various meaning or use in the treatment of cancer.
    Type: Application
    Filed: August 12, 2015
    Publication date: December 3, 2015
    Inventors: Alberto Rodriquez Vicente, Maria Garranzo Garcia-lbarrola, Carmen Murcia Perez, Francisco Sanchez Sancho, Maria del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digon Juarez
  • Antitumoral compounds
    Patent number: 9187445
    Abstract: A compound of general formula (I) wherein A, Y, W, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: November 17, 2015
    Assignee: PHARMA MAR, S.A.
    Inventors: Alberto Rodríguez Vicente, María Garranzo García-Ibarrola, Carmen Murcia Pérez, Francisco Sánchez Sancho, María del Carmen Cuevas Marchante, Cristina Mateo Urbano, Isabel Digón Juárez
  • Anticancer steroidal lactones unsaturated in position 7 (8)
    Patent number: 8962602
    Abstract: A compound of general formula (I), wherein R1-R17 and the - - - - - - line take various meanings for use in the treatment of cancer.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: February 24, 2015
    Assignee: Pharma Mar, S.A.
    Inventors: Rogelio Fernández Rodríguez, José Fernando Reyes Benítez, Andrés Francesch Solloso, María del Carmen Cuevas Marchante
  • Antitumoral compounds
    Patent number: 8748388
    Abstract: Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof useful as antitumour agents.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: June 10, 2014
    Assignee: Pharma Mar, S.A.
    Inventors: Judit Tulla-Puche, Eleonora Marcucci, Núria Bayó-Puxan, Fernando Albericio, Maria del Carmen Cuevas Marchante